to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Paul Yock interviews Howard Holstein, regulatory attorney, on understanding the FDA.
Elizabeth A. Holmes is President and Chief Executive Officer of Theranos, Inc. Holmes left Stanford University in 2003 at the age of 19 to pursue her company, and she successfully raised $6 million in venture capital
from many firms, including Draper Fisher Jurvetson. Holmes' unique background in microfluidics and nanotechnology led her to found Theranos based on her patent, Medical Device for Analyte Monitoring and Drug Release. The invention and the
company are based on her vision to create a new sector of personalized health care that enables individuals to take control of their health through real-time diagnosis, monitoring, and non-invasive treatment of targeted ailments. She took
the company from concept to reality, building a management team and leading the product and commercial development infrastructures. Previous to Theranos, while Holmes was still in high school, she started a business to distribute C++
software to Asian universities. Holmes has also worked for Genencor International, the Genome Institute Singapore, and she?s acted as Executive Director of Stanford University's Asia Technology Initiative.
Dr. John Hennessy has been President of Stanford University since 2000. He became a Stanford faculty member in 1977. He rose through the academic ranks to full professorship in 1986 and was the inaugural Willard R. and
Inez Kerr Bell Professor of Electrical Engineering and Computer Science from 1987 to 2004. A pioneer in computer architecture, in 1981 Dr. Hennessy drew together researchers to focus on a computer architecture known as RISC (Reduced
Instruction Set Computer), a technology that has revolutionized the computer industry by increasing performance while reducing costs. In 1984, he used his sabbatical year to found MIPS Computer Systems Inc. to commercialize his research in
RISC processors. Dr. Hennessy is a recipient of the 2000 IEEE John von Neumann Medal, a 2004 NEC C&C Prize for lifetime achievement in computer science and engineering, and a 2005 Founders Award from the American Academy of Arts and
Sciences. Dr. Hennessy earned his bachelor's degree in electrical engineering from Villanova University and his master's and doctoral degrees in computer science from the State University of New York at Stony Brook.
Jeff Hawkins is the Founder of Numenta, but he is also well known as the co-founder of two companies, Palm and Handspring, and as the architect of many computing products, such as the PalmPilot and the Treo smartphone.
Throughout his life Hawkins has also had a deep interest in neuroscience and theories of the neocortex. His interest in the brain led him to create the non-profit Redwood Neuroscience Institute (RNI), a scientific organization focused on
understanding how the human neocortex processes information. While at RNI, Hawkins developed a theory of neocortex which appeared in his 2004 book, On Intelligence. Along with Dileep George and Donna Dubinsky, Hawkins
founded Numenta in 2005 to develop a technology platform derived from his theory. It is his hope that Numenta will play a catalytic role in creating an industry based on this theory and technology. Jeff Hawkins earned his B.S. in
electrical engineering from Cornell University in 1979. He was elected to the National Academy of Engineering in 2003.
Danish-born David Heinemeier Hansson is the programmer and creator of the popular Ruby on Rails web development framework and the Instiki wiki. He is also a partner at the Web-based software development firm 37signals,
based in Chicago. Ruby on Rails provides a "basic development environment" for programmers, according to Wikipedia.org. Based on the programming language Ruby (developed by Japanese programmer Yukihiro Matsumoto in 1995), Ruby on Rails
focuses on user interface and "convention over configuration"; meaning, developers can focus on the unique qualities of their Web site or program rather than the building blocks that every application may require. Released in 2004, Ruby on
Rails has been incorporated into many applications used by some of the biggest companies, from Twitter to Apple's 2007 release of Mac OS X v.10.5 "Leopard." Aside from his development of Ruby on Rails, Heinemeier Hansson also works as a
partner for Web-based software development firm 37signals. Joining the company in 2003, he has helped develop Basecamp, Campfire, Backpack and other Web-based applications. Working in similar ways like Web-based e-mail services like Yahoo!
e-mail and Google's Gmail, 37signals hosts a broad range of IT services for companies, including project management to information-sharing. The firm's software has been used by Kellogg's, Sun Microsystems and even Obama '08. Hansson
received his bachelor's degree from the Copenhagen Business School in 2005. In that same year, he moved to Chicago and received Hacker of the Year honors for his work on Ruby on Rails from Google and O'Reilly Media. He runs a blog called
Bill Gross thrives on turning innovative ideas into pioneering companies. He serves as founder and CEO of Idealab, which started over 75 companies since 1996. In this stimulating lecture, he shares how Idealab continues to bring incredible ideas to market, and his personal insights on starting and running successful organizations. Gross also describes the work of eSolar, a spin-off company of Idealab that works to make solar energy cost-competitive in the global marketplace.
This accomplished entrepreneur matches practical tips from Peter Drucker's book, Innovation and Entrepreneurship, with innovative product moves developed by real-life growth companies. The entrepreneur author shows how these companies apply key tactics, such as tracking demographics and customer preferences, that are detailed as principles by Drucker.
Are bioresorbable stents from one company better than another? Arterial Remodeling Technologies thinks so. The company boasts that its stents offer faster and smoother bioresorption and crack-free expansion.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.